Graf Akcie BBI (Brickell Biotech Inc). Diskuze k akciím BBI. Aktuální informace BBI.

Základní informace o společnosti Brickell Biotech Inc (Akcie BBI)

Skvělé pro velmi rychlou analýzu společnosti. Investor může porovnat různé ukazatele s konkurenčními firmami.

Tržní kapitalizace 51.52M
Hodnota podniku (EV) 37.45M
Tržby 337.000k
EBITDA -32.32
Zisk -31.85
Růst v tržbách Q/Q -75.12 %
Růst v tržbách Y/Y -90.39 %
P/E (Cena vůči ziskům) N/A
Forward P/E -0.02
EV/Sales 111.13
EV/EBITDA N/A
EV/EBIT N/A
PEG N/A
Price/Sales 152.89
P/FCF N/A
Price/Book 1.90
Účetní hodnota na akcii 0.31
Hotovost na akcii 0.34
FCF vůči ceně -56.30 %
Počet zaměstnanců 13
Tržba na zaměstnance 25.923k
Profit margin -1,147.80 %
Operating margin -9,593.77 %
Gross margin 100.00 %
EBIT margin -9,430.56 %
EBITDA margin -9,590.21 %
EPS - Zisk na akcii N/A
EPS - Kvartální růst N/A %
EPS - Očekávaný růst příští rok -20.00 %
Return on assets -99.55 %
Return on equity -130.86 %
ROIC -80.78 %
ROCE -141.95 %
Dluhy/Equity 0.24
Čistý dluh/EBITDA 3.35
Current ratio 4.33
Quick Ratio 4.33
Volatilita 6.55
Beta 0.81
RSI 28.73
Cílová cena analytiků 6
Známka akcie (dle analytiků) 1.00
Insider ownership 1.71 %
Institutional ownership 17.62 %
Počet akcií 85.915M
Procento shortovaných akcií 3.03 %
Short ratio 3.72 %
Dividenda N/A
Procentuální dividenda N/A %
Dividenda/Zisk N/A %
Obchodovaná od 2007
Země United States

Finanční výsledky akcie BBI

Finanční výsledky společnosti, napoví investorovi, zda se jedná o kvalitní společnost.

# 2020 2019 2018 2017 2016 2015
Revenue$7.917$10.888$13.819$14.531$20.95$15.217
Cost Of Goods Sold--$6.479$6.291$10.927$10.824
Gross Profit$7.917$10.888$7.34$8.24$10.023$4.393
Research And Development Expenses$20.214$12.96$14.391$10.355$11.061$11.467
SG&A Expenses$12.171$6.379$6.335$7.062$8.366$9.552
Other Operating Income Or Expenses------
Operating Expenses$32.385$19.339$27.205$23.708$30.354$31.843
Operating Income$-24.468$-8.451$-13.386$-9.177$-9.404$-16.626
Total Non-Operating Income/Expense$0.591$-0.785$0.426$0.204$0.166$0.134
Pre-Tax Income$-23.877$-9.236$-12.96$-8.973$-9.238$-16.492
Income Taxes------
Income After Taxes$-23.877$-9.236$-12.96$-8.973$-9.238$-16.492
Other Income------
Income From Continuous Operations$-23.877$-9.236$-12.96$-8.973$-9.238$-16.492
Income From Discontinued Operations------
Net Income$-13.603$-15.172$-12.96$-8.973$-9.238$-16.492
EBITDA$-22.865$-7.913$-12.593$-7.686$-8.015$-14.963
EBIT$-24.468$-8.451$-13.386$-9.177$-9.404$-16.626
Basic Shares Outstanding312111
Shares Outstanding312111
Basic EPS$-4.50$-25.85$-7.07$-6.30$-7.07$-13.02
EPS - Earnings Per Share$-4.50$-25.85$-7.07$-6.30$-7.07$-13.02
# 2020 2019 2018 2017 2016 2015
Current Ratio1.71180.41164.51136.699410.69159.8693
Long-term Debt / Capital------
Debt/Equity Ratio--0.0648----
Gross Margin10010053.115356.706447.842528.869
Operating Margin-309.0565-77.6176-96.8666-63.1546-44.8878-109.2594
EBIT Margin-309.0565-77.6176-96.8666-63.1546-44.8878-109.2594
EBITDA Margin-288.8089-72.6764-91.1281-52.8938-38.2578-98.3308
Pre-Tax Profit Margin-301.5916-84.8273-93.7839-61.7507-44.0955-108.3788
Net Profit Margin-171.8201-139.3461-93.7839-61.7507-44.0955-108.3788
Asset Turnover0.43631.24450.17170.27790.41970.2625
Inventory Turnover Ratio------
Receiveable Turnover--2.69694.24634.61053.6422
Days Sales In Receivables--135.339785.956279.1675100.2149
ROE - Return On Equity-315.249712.8962-20.3847-19.8786-20.3512-31.763
Return On Tangible Equity-315.249612.8173-20.6127-20.2418-20.9512-32.8121
ROA - Return On Assets-131.5972-105.5664-16.1006-17.162-18.5078-28.4448
ROI - Return On Investment-315.249612.8962-20.3847-19.8786-20.3512-31.763
Book Value Per Share0.8931-121.592520.406628.581134.701340.2224
Operating Cash Flow Per Share-18.660511.42831.1885-0.55942.429216.2839
Free Cash Flow Per Share-18.642311.45121.3232-0.68482.431716.4567